Information
82 Bugok-ro, Pogok-eup, Cheoin-gu, Yongin-si, Gyeonggi-do, South Korea
-
-
Overview
- Summary
- VASNOVA is a specialized company researching, manufacturing, distributing, and selling vascular and non-vascular stents and related devices. A medical tech company developing vascular treatment solutions based on precision design and customized manufacturing technology. Possessing capabilities for developing and producing stent grafts with proprietary technology for high-difficulty vascular diseases such as aortic aneurysms and aortic dissections. A corporate philosophy pursuing new innovations in the field of vascular treatment.VASNOVA is a specialized company researching, manufacturing, distributing, and selling vascular and non-vascular stents and related devices. A medical tech company developing vascular treatment solutions based on precision design and customized manufacturing technology. Possessing capabilities for developing and producing stent grafts with proprietary technology for high-difficulty vascular diseases such as aortic aneurysms and aortic dissections. A corporate philosophy pursuing new innovations in the field of vascular treatment.
- Key Products/Technologies
- A specialized technology company in the field of vascular stent grafts.A specialized technology company in the field of vascular stent grafts.
- Holding 'SEAL Aortic Stent Graft' as a flagship product.Holding 'SEAL Aortic Stent Graft' as a flagship product.
- This product features a thinner insertion device compared to existing products, minimizing the risk of vascular damage during procedures and supporting precise intervention by medical professionals.This product features a thinner insertion device compared to existing products, minimizing the risk of vascular damage during procedures and supporting precise intervention by medical professionals.
- The proprietary 'K-all' wire technology is an innovative technique securing strong support through a unique structure of interwoven thin wires.The proprietary 'K-all' wire technology is an innovative technique securing strong support through a unique structure of interwoven thin wires.
- Capabilities for customized manufacturing of stent grafts for cylindrical and branched (Y-shaped) vascular structures using in-house ultra-precision weaving technology.Capabilities for customized manufacturing of stent grafts for cylindrical and branched (Y-shaped) vascular structures using in-house ultra-precision weaving technology.
- A product line introducing 'SEAL Fenestrated Aortic Stent Graft' applicable to patients with complex aortic structures.A product line introducing 'SEAL Fenestrated Aortic Stent Graft' applicable to patients with complex aortic structures.
- Technological prowess accelerating the development of high-difficulty treatment solutions by adopting AI-based development systems, digital twin, and smart manufacturing.Technological prowess accelerating the development of high-difficulty treatment solutions by adopting AI-based development systems, digital twin, and smart manufacturing.
- Research and development expanding the product portfolio to cover the entire vascular domain, including cardiovascular and cerebrovascular areas.Research and development expanding the product portfolio to cover the entire vascular domain, including cardiovascular and cerebrovascular areas.
- Core Advantages
- Accumulated technological know-how and top-tier industry expertise over 26 years, originating from Asan Medical Center's Interventional Medicine Research Lab and Ulsan University's Biomedical Engineering Lab.Accumulated technological know-how and top-tier industry expertise over 26 years, originating from Asan Medical Center's Interventional Medicine Research Lab and Ulsan University's Biomedical Engineering Lab.
- Ability to provide patient-specific solutions based on proprietary wire support structure and ultra-precision graft manufacturing technology.Ability to provide patient-specific solutions based on proprietary wire support structure and ultra-precision graft manufacturing technology.
- Securing technological superiority by building a core patent portfolio of 58 domestic and international patents.Securing technological superiority by building a core patent portfolio of 58 domestic and international patents.
- The thin insertion device of the 'SEAL Aortic Stent Graft' is a differentiating factor, minimizing patient vascular damage risk and assisting precise procedures by medical professionals.The thin insertion device of the 'SEAL Aortic Stent Graft' is a differentiating factor, minimizing patient vascular damage risk and assisting precise procedures by medical professionals.
- An innovative management system introducing AI design, digital twin, and smart manufacturing, setting new standards for patient-specific treatment.An innovative management system introducing AI design, digital twin, and smart manufacturing, setting new standards for patient-specific treatment.
- Securing growth momentum by establishing R&D-centric innovation management after the appointment of CEO Kwak Jae-oh, with 25 years of experience in the global medical device sector.Securing growth momentum by establishing R&D-centric innovation management after the appointment of CEO Kwak Jae-oh, with 25 years of experience in the global medical device sector.
- Achieving an estimated 10.7% market share in the domestic vascular stent graft market as of 2025, with a goal to expand to over 20% by 2030.Achieving an estimated 10.7% market share in the domestic vascular stent graft market as of 2025, with a goal to expand to over 20% by 2030.
- Technological capability contributing to improved patient outcomes through enhanced long-term patency and reduced re-intervention rates.Technological capability contributing to improved patient outcomes through enhanced long-term patency and reduced re-intervention rates.
- Target Industrie
- Medical device manufacturing and development industry.Medical device manufacturing and development industry.
- Vascular disease treatment sector, particularly for severe aortic diseases such as aortic aneurysms and aortic dissections.Vascular disease treatment sector, particularly for severe aortic diseases such as aortic aneurysms and aortic dissections.
- Interventional procedure device development and supply industry.Interventional procedure device development and supply industry.
- Planned expansion of product portfolio into cardiovascular and cerebrovascular disease treatment areas.Planned expansion of product portfolio into cardiovascular and cerebrovascular disease treatment areas.
- Major Markets
- Indonesia, Hong Kong, Vietnam, Kyrgyzstan, PakistanIndonesia, Hong Kong, Vietnam, Kyrgyzstan, Pakistan
- RussiaRussia
- United States (targeting market entry after FDA approval in 2031)United States (targeting market entry after FDA approval in 2031)
- Certifications/Patents
- Possession of a core patent portfolio comprising 58 domestic and international patents.Possession of a core patent portfolio comprising 58 domestic and international patents.
- Technological capability where the proof regarding stent structure is evaluated as globally superior.Technological capability where the proof regarding stent structure is evaluated as globally superior.
- A plan to pursue entry into major markets with the goal of obtaining US FDA approval by 2031.A plan to pursue entry into major markets with the goal of obtaining US FDA approval by 2031.
- Technological advantage through proprietary wire support structure and ultra-precision graft manufacturing technology.Technological advantage through proprietary wire support structure and ultra-precision graft manufacturing technology.
Introduction
Location
82 Bugok-ro, Pogok-eup, Cheoin-gu, Yongin-si, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
